Carvedilol

CAS 72956-09-3 23 API suppliersSmall Molecule

Overview

Carvedilol is a non-selective beta blocker with alpha-1 blocking activity primarily used for the treatment of mild to moderate congestive heart failure and hypertension. It helps to decrease heart rate and dilate blood vessels to improve blood flow.

API suppliers (24)

Suppliers of Carvedilol evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India11Netherlands1Spain1China1Israel1United States1USA1Hungary1

Country recorded for 18 of 24 suppliers.

16 of 24 hold a GMP certificate on record in the EU or UK registers · 1 holds a European CEP for this substance

Patent & exclusivity (US)

Per the FDA Orange Book (56 approved US products), the latest listed US patent on Carvedilol expires 11 Mar 2026. Generic API sourcing typically opens up once these lapse.

Therapeutic areas

Cardiovascular DiseasesHeart FailureHypertension
Verified Supplier Partner

Do you supply Carvedilol? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.